A Retrospective Study Evaluating Frequency and Risk Factors of Osteonecrosis of the Jaw in 576 Cancer Patients Receiving Intravenous Bisphosphonates

Sent to you via Google Reader

A Retrospective Study Evaluating Frequency and Risk Factors of Osteonecrosis of the Jaw in 576 Cancer Patients Receiving Intravenous Bisphosphonates

Retrospective analysis of 576 cancer patients treated with intravenous bisphosphonates found that 3.1% developed osteonecrosis of the jaw, 59% of which followed tooth extraction. Diabetes, hypothyroidism,...